Insiders Bridge Biotherapeutics, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-23 EDT			5-day change	1st Jan Change
2,110 ^KRW	+4.46%		-4.95%	-35.77%

03-28	Bridge Biotherapeutics Launches Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade	CI
03-26	Bridge Biotherapeutics Announces Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology	CI

No results for this search